MedTrace Logo

Magnetic Resonance Imaging in Treating Children With Progressive Low-Grade Astrocytoma

NCT00005084 · Status: UNKNOWN · Phase: PHASE2 · Type: INTERVENTIONAL · Enrollment: 24

Last updated 2013-12-18

No results posted yet for this study

Summary

RATIONALE: New imaging procedures such as magnetic resonance imaging may improve the ability to determine the growth rate of progressive astrocytoma.

PURPOSE: Phase II trial to study the effectiveness of magnetic resonance imaging in treating children who have progressive low-grade astrocytoma.

Conditions

Interventions

PROCEDURE

conventional surgery

PROCEDURE

magnetic resonance spectroscopic imaging

RADIATION

radiation therapy

Sponsors & Collaborators

  • National Cancer Institute (NCI)

    collaborator NIH

  • Jonsson Comprehensive Cancer Center

    lead OTHER

Principal Investigators

  • Jeffry Alger, PhD · Jonsson Comprehensive Cancer Center

Study Design

Purpose
TREATMENT

Eligibility

Max Age
12 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
1999-02-28

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00005084 on ClinicalTrials.gov